ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EDEN Eden Research Plc

4.45
0.00 (0.00%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.45 4.30 4.60 4.45 4.45 4.45 287,855 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.60 23.73M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.45p. Over the last year, Eden Research shares have traded in a share price range of 3.675p to 10.25p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £23.73 million. Eden Research has a price to earnings ratio (PE ratio) of -10.60.

Eden Research Share Discussion Threads

Showing 16626 to 16649 of 18300 messages
Chat Pages: Latest  672  671  670  669  668  667  666  665  664  663  662  661  Older
DateSubjectAuthorDiscuss
03/1/2024
13:19
Eden Research plc @edenresearch

We’re looking forward to a year of growth and the fruitful development of our relationship with @sumi_agro Poland!

supersonico
03/1/2024
10:21
As they say Healthy two-way trade.
alchemy
03/1/2024
08:27
It was Neuts.
timbo_slice
03/1/2024
08:19
Bid up next please . That's a big spread.
alchemy
03/1/2024
08:16
Someone's keen 100k buy at 8am
monet
02/1/2024
17:06
Brucie5

"4. insecticide"

You will see it soon as SS said on the recent Proactive video

investingisatrickygame
02/1/2024
17:00
Chart does looked primed for take off. The share price moves very fast either way on newsflow. Obviously I/we have no idea whether the sales with amount to anything; so far in the share's history, they haven't.
But I would say a number of things in favour (please correct if wrong!)
1. fully cashed up for next two years.
2. marketing/sales for their blockbuster, ecovelex, managed through Corteva, so now that it has emergency acceptance in Italy, there is little for EDEN to mess up. This for me is the short term driver to look forward to.
3. MEV/CED will continue to expand geographically, including US with potential multiplier effect of label extensions.
4. Insecticide: we'll believe it when we see it!

I hold a modest position but delighted to see it's up by 50% from purchase price. High risk.

brucie5
02/1/2024
16:46
plenty of afternoon buys ? news coming ? leaky ship ?
jeanesy
02/1/2024
16:25
You’re fighting against the tide. Momentum might only be small at the moment, but 2024 is going to be transformational for Eden.
kittybiscuits
02/1/2024
15:55
Hahahaahaaaa!!

The monkeys and twits haven't noticed the Bid-Offer spread, have they, ravenna23?

Or don't they understand they can only lose money trying to trade this ordure?

(chuckle, frappe)

neutralpov
02/1/2024
15:18
I don't usually go for analysis based on years - New Years wear off but I like the promise of this one!
alchemy
02/1/2024
13:28
Sports people and TV presenters collapsing that you never saw before 2021..and the Canary told you so..but everyone else seems to be 'baffled'.

Chief Nerd
@TheChiefNerd
The data is available now. Excess deaths are rising. The life expectancy in the United States of America is falling and it isn’t because of COVID…Curiously there is a total lack of appetite to investigate this…

supersonico
02/1/2024
12:51
So good with words!Just to recall there was a single post last year from domeone who had been to the investor presentation . I forget their exact summary but they were pretty certain of success. There have been great posts from the select few i csll the informed positives. but they won't mind me saying that was the post of the year .
alchemy
02/1/2024
12:28
Alchemy 2 Jan '24 - 08:04 - 16212
> Added a tidgy amount

"Tidgy" is more accurate than "Tidy", given the tidgy nature of the shytestock, ROFL!

;D and cawfee

neutralpov
02/1/2024
10:05
U.S. M&A Deals Under $1 Million
supersonico
02/1/2024
08:04
Added a tidgy amount
alchemy
01/1/2024
23:51
My last two predictions have been bang on thank you. First was that ITALTY approval would come through for Ecovelux and 2nd was that you wouldn’t pay up for the bet that you lost, just a matter of days after you made the wager. I was 100% correct on both.
kittybiscuits
01/1/2024
22:29
KittyBiscuits 1 Jan '24 - 20:29 - 16209
> I predict California approval in January.

ROTFL!!!!

Which will work out exactly like all the other predictions you've made for, what's it, 15 years now, using any number of different IDs, in respect of wonderful prospects of all the shytestock companies which you've pushed.... ones in which only the directors and close mates prosper (no, you have no seat at the table, lol), and it all ends up in the hands of the prepackage-operators, debenture holders, etc... and we don't even get the pleasure of seeing the filthy BoDs jailed.

Genuine investors, nothing for you here, only tricks by paid ramping liars and moronic trapped bulls.

Happy New Year. ;-)

neutralpov
01/1/2024
20:29
I predict California approval in January.
kittybiscuits
01/1/2024
16:57
Not that further proof was needed, but this odd acronym "AWGATWT" above can only be found twice in the whole of ADVFN, ever.

Both occurrences in the EDEN ramping scamthread.

supersonico 17/7/2023 17:32
and
supersonico 1/1/2024 10:40

(chuckle)

neutralpov
01/1/2024
15:42
I predict #3

UPL.

supersonico
01/1/2024
14:39
The insecticide, according to Eden, has been trialled in 140 locations around the world. That kind of global trial and reach has never been done on an Eden product, has it?

There are multiple interested and trialling parties for the insecticide. As AttyG says, if it is Syngenta, one might reasonably assume that they would have global right's. Furthermore, Eden's insecticide will deal with 4 insects in one application where I think the norm is 2. I stand to be corrected on that.

So global right's on Eden's organic/green (status allocated or not) and micro-plastics free insecticide will surely be the biggest deal in the company's history. How could it not be?! Ecovelex hasn't reached that status yet as right's are only contracted to Corteva in Europe.

If Ecovelex is a game-changer for Eden and Cedroz and Mevalone start delivering around the world including the US, primarily California, then as AttyG says, shareholders are going to do extremely well.

I imagine when Mevalone California is confirmed and the insecticide deal is announced and assuming Eden clearly messages in layman's terms the real significance of these two announcements, that investors will come running into the stock and the share price will react accordingly, upwards.

Again, as AttyG has stated from the Cenkos notes, Eden has very good product margins. Work out the potential profits, divide it by the shares in issue and apply your multiple of 20-30, 40 if your ambitious.

All this with 20 staff and operational running costs of currently, sub £3 million per annum.

investingisatrickygame
01/1/2024
14:13
I agree with all three predictions - though I too, am simply reading the tea leaves.

All three are individual game changers.

Any deal with Syngenta would deliver a minimum of £10m sales in year one.
Syngenta (or any of the other parties trialling products with Eden) are not doing this for a £500k niche sales line - they will be doing it to replace a strong product, possibly making it organic but certainly making it micro plastic free. It would (all in my view) be the start of transitioning multiple products to Eden’s co encapsulation IP - the future’s bright, the future is sustaine outside.

California approval - and I also expect this in the first quarter - will be a proper game changer for US sales and thus US recognition.
The US market is in many aspects a bit of a holy grail - all one needs to do is read any of the longer Cenkos notes to understand the importance of a proper breakthrough in the US.

French approval for ecovelex will inevitably lead to the rest of the EU approving ecovelex. Well, never mind the sunflowers or soybeans - we will all be rich with just one product for just one crop in just one economic grouping in just one of the three industries (Agriculture; Human health and Animal health) in which Eden’s IP can be utilised.

attyg
01/1/2024
12:42
I predict#2

Syngenta.

supersonico
Chat Pages: Latest  672  671  670  669  668  667  666  665  664  663  662  661  Older